Effects of naltrexone and fluoxetine on alcohol self-administration and reinstatement of alcohol seeking induced by priming injections of alcohol and exposure to stress

Neuropsychopharmacology

Volumn 21, Issue 3, 1999, Pages 435-444

  Le A D ^b   Poulos, C X ^a,c   Harding, S ^a   Watchus, J ^a   Juzytsch, W ^a   Shaham, Y ^d  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Alcohol; Drug self administration; Fluoxetine; Naltrexone; Opioid receptors; Reinstatement; Relapse; Serotonin; Stress

Indexed keywords

ALCOHOL; FLUOXETINE; NALTREXONE; OPIATE RECEPTOR; SEROTONIN;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG SELF ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS; SUBCUTANEOUS DRUG ADMINISTRATION;

ALCOHOL DETERRENTS; ALCOHOL DRINKING; ANIMALS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; ETHANOL; FLUOXETINE; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; RATS; SELF ADMINISTRATION; STRESS;

EID: 0032815730     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(99)00024-X     Document Type: Article

References (64)

1. Abe M., Nakai H., Tabata R., Saito K., Egawa M. Effect of 5-[3-[((2S)-1,4-benzodioxan-2-ylmethyl)amino]propoxy]-1,3-benzodioxole HCl (MKC-242), a novel 5-HT1A-receptor agonist, on aggressive behavior and marble burying behavior in mice. Jpn J Phrmacol. 76:1998;297-304.
2. Aggleton J.P. The amygdala. neurobiological aspects of emotion, memory, and mental dysfunction:1992;Wiley-Liss, New York.
3. Akil H., Madden J., Patrick R.L., Barchas J.D. Stress-induced increase in endogenous opiate peptides. Concurrent analgesia and its partial reversal by naloxone Kosterlits H.W. Opiates and Endogenous Opioid Peptides. 1976;63-70 The Netherlands, Elsevier, Amsterdam.
4. Akunne H.C., Soliman K.F. Serotonin modulation of pain responsiveness in the aged rat. Pharmacol Biochem Behav. 48:1994;411-416.
5. Amit Z., Galina H. Stress-induced analgesia. Adaptive pain suppression Physiol Rev. 66:1986;1091-1120.
6. Amit Z., Smith B.R., Gill K. Serotonin uptake inhibitors. Effects on motivated consummatory behaviors J Clin Psychiatry. 52(suppl):1991;55-60.
7. Bigelow G.E., Griffiths R.R., Liebson I.A. Pharmacological influences upon human ethanol self-administration. Gross M.M. Alcohol intoxication and withdrawal. 1977;523-538 Plenum Press, New York.
8. Bliss E.L., Thatcher W., Ailion J. Relationship of stress to brain and serotonin and 5-hydroxyindoleacetic acid. J Psychiatry Res. 9:1972;71-80.
9. Bodnoff S.R., Suranyi-Cadotte B., Quirion R., Meaney M.J. A comparison of the effects of diazepam versus several typical and atypical anti-depressant drugs in an animal model of anxiety. Psychopharmacology. 97:1989;277-279.
10. Brown S.A., Vik P.W., Patterson T.L., Grant I., Schuckit M.A. Stress, vulnerability and adult alcohol relapse. J Stud Alcohol. 56:1995;538-545.
11. Cannon W.B. Stresses and strains of homeostasis. Am J Med Sci. 189:1935;1-14.
12. Carroll M.E., Comer S.D. Animal models of relapse. Exp Clin Psychopharmacol. 4:1996;11-18.
13. Chaouloff F. Physiopharamcological interactions between stress hormones and central serotonergic systems. Brain Res Rev. 18:1993;1-32.
14. Cooper M.L., Russell M., Skinner J.B., Frone M.R., Mudar P. Stress and alcohol use. Moderating effects of gender, coping and alcohol expectancies J Abnorm Psychol. 101:1992;139-152.
15. de Wit H. Priming effects with drugs and other reinforcers. Exp Clin Psychopharmacol. 4:1996;5-10.
16. de Wit H., Chutuape M.A. Increased ethanol choice in social drinkers following ethanol preload. Behav Pharmacol. 4:1993;29-36.
17. De Vry J., Benz U., Schreiber R., Traber J. Shock-induced ultrasonic vocalization in young adult rats. A model for testing putative anti-anxiety drugs Eur J Pharmacol. 16:1993;331-339.
18. Erb S., Shaham Y., Stewart J. Stress reinstates cocaine-seeking behavior after prolonged extinction and drug-free periods. Psychopharmacology. 128:1996;408-412.
19. Erb S., Mueller D., Shaham Y., Leung S., Stewart J. Effect of clonidine on stress- and drug induced relapse to heroin and cocaine seeking. Soc Neurosci Abstr. 24:1998;498. a.
20. Erb S., Shaham Y., Stewart J. The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats. J Neurosci. 14:1998;5529-5536. b.
21. Fuller R.W. Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis. Life Sci. 55:1994;163-167.
22. Fuller R.W., Snoody H.D. Serotonin receptors subtypes involved in the elevation of serum corticosterone concentration in rats by direct- and indirect serotonin agonists. Neuroendocrinology. 52:1990;206-211.
23. Gonzales R.A., Weiss F. Suppression of ethanol-reinforced behavior by naltrexone is associated with atenuation of ethanol-induced increase in dialysate dopamine levels in the nucleus accumbens. J Neurosci. 18:1998;10663-10671.
24. Grignaschi G., Samanin R. Role of serotonin and catecholaines in brain in the feeding suppressant effect of fluoxetine. Neuropharmacology. 31:1992;445-449.
25. Griebel G., Blanchard D.C., Agnes R.S., Blanchard R.J. Differential modulation of antipredator defensive behavior in Swiss-Webster mice following acute and chronic administration of imipramine and fluoxetine. Psychopharmacology. 120:1995;57-66.
26. Griebel G., Rodgers R.J., Perrault G., Sanger D.J. Risk assessment behaviour. evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test Pharmacol Biochem Behav. 57:1997;817-827.
27. Haraguchi M., Samson H.H., Tolliver G.A. Reduction in oral ethanol self-administration in the rat by the 5-HT uptake blocker fluoxetine. Pharmacol Biochem Behav. 35:1990;259-262.
28. Herz A. Endogenous opioid systems and alcohol addiction. Psychopharmacology. 129:1997;99-111.
29. Hodgson R., Rankin H., Strickwell T. Alcohol dependence and the priming effect. Behav Res Ther. 17:1979;379-387.
30. Hore B.D. Factors in alcoholic relapse. Brit J Addict. 66:1971;89-96.
31. Hyytia P., Sinclair J.D. Responding for oral ethanol after naltrexone treatment by alcohol-preferring AA rats. Alcoholis: Clin Exp Res. 17:1993;631-636.
32. Kirby L.G., Allen A.R., Lucki I. Regional differences in the effects of forced swimming on extracellular levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid. Brain Res. 682:1995;189-196.
33. Kirby L.G., Lucki I. Interaction between the forced swimming test and fluoxetine treatment on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the rat. J Pharmacol Exp Ther. 282:1997;967-976.
34. Lê A.D., Tomkins D.M., Sellers E.M. Uses of serotonin and opiate based drugs in the pharmacotherapy of alcohol dependence. An overview of the preclinical data Alcohol Alcoholism. 31:1996;27-32.
35. Lê A.D., Quan B., Juzystch W., Fletcher P.J., Joharchi N., Shaham Y. Reinstatement of alcohol-seeking by priming injections of alcohol and exposure to stress in rats. Psychopharmacology. 135:1998;169-174.
36. Linseman M.A. Alcohol consumption in free feeding rats. Procedure, genetic and pharmacokinetic factors Psychopharmacology. 92:1987;254-261.
37. Ludwig A.M., Wikler A., Stark L.H. The first drink. Psychobiological aspects of craving. Arch Gen Psychiatry. 30:1974;539-547.
38. Messing R.B., Phebus L., Fisher L.A., Lytle L.D. Analgesic effect of fluoxetine hydrochloride (Lilly 110140), a specific inhibitor of serotonin uptake. Psychopharmacol Commun. 1:1975;511-521.
39. Murphy J.M., Waller M.B., Gatto G.J., McBride W.J., Lumeng L., Li T.K. Effects of fluoxetine on the intragastric self-administration of ethanol in the alcohol preferring P line of rats. Alcohol. 5:1988;283-286.
40. Naranjo C.A., Sellers E.M. Serotonin uptake inhibitors attenuate ethanol intake in problem drinkers. Recent Dev Alcohol. 7:1989;255-266.
41. Nelson C.J., Jordan W.P., Bohan R.T. Daily fluoxetine administration impairs avoidance learning in the rat without altering sensory thresholds. Prog Neuropsychopharmacol Biol Psychiatry. 21:1997;1043-1057.
42. O'Malley S.S., Jaffe J.H., Chang G., Schottenfeld R.S., Meyer R.E., Rounsaville B.J. Naltrexone and coping skills therapy for alcohol dependence. A controlled study Arch Gen Psychiatry. 49:1992;881-887.
43. Rueter L.E., Fornal C.A., Jacobs B.L. A critical review of 5-HT brain microdialysis and behavior. Rev Neurosci. 8:1997;117-137.
44. Sanchez C., Meier E. Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike? Psychopharmacology. 129:1997;197-205.
45. Sanger D.J., Blackman D.E. Rate-dependent effects of drugs. A review of the literature Pharmacol Biochem Behav. 4:1976;73-83.
46. Schwarz-Stevens K.S., Files F.J., Samson H.H. Effects of morphine and naloxone on ethanol- and sucrose-reinforced responding in non-deprived rats. Alcoholism: Clin Exp Res. 16:1992;822-832.
47. Sellers E.M., Higgins G.A., Sobell M.B. 5-HT and alcohol abuse. Trends Pharmacol Sci. 13:1992;69-75.
48. Selye H. The stress of life. 1956;McGraw-Hill, New York.
49. Shaham Y. Effect of stress on opioid-seeking behavior. Evidence from studies with rats Annal Behav Med. 18:1996;255-263.
50. Shaham Y., Stewart J. Stress reinstates heroin self-administration behavior in drug-free animals. An effect mimicking heroin, not withdrawal Psychopharmacology. 119:1995;334-341.
51. Shaham Y., Stewart J. Effects of opioid and dopamine receptor anatgonist on relapse induced by stress and re-exposure to heroin in rats. Psychopharmacology. 125:1996;385-391.
52. Shaham Y., Rajabi H., Stewart J. Relapse to heroin-seeking under opioid maintenance. the effects of opioid withdrawal, heroin priming and stress J Neurosci. 16:1996;1957-1963.
53. Shaham Y., Funk D., Erb S., Brown T.J., Walker C.D., Stewart J. Corticotropin-releasing factor, but not cortico sterone, is involved in stress-induced relapse to heroin-seeking in rats. J Neurosci. 17:1997;2605-2614.
54. Shaham Y., Erb S., Leung S., Buczek Y., Stewart J. CP-154,526, a selective, non peptide antagonist of the corticotropin-releasing factor type 1 receptor attenuates stress-induced relapse to drug seeking in cocaine-and heroin-trained rats. Psychopharmacology. 137:1998;184-190. a.
55. Shaham Y., Leung S., McDonald R.J., Stewart J. Disruption of inhibitory processes may be involved in stress-induced relapse to heroin. Soc Neurosci Abstr. 24:1998;498. b.
56. Sinclair J.D., Senter R.J. Increased preference for ethanol in rats following alcohol deprivation. Psychonom Sci. 8:1967;11-16.
57. Stewart J. Reinstatement of heroin and cocaine self-administration behavior in the rat by intracerebral application of morphine in the ventral tegmental area. Pharmacol Biochem Behav. 20:1984;917-923.
58. Stewart J., de Wit H. Reinstatement of drug-taking behavior as a method of assessing incentive motivational properties of drugs. Bozarth M.A. Methods of assessing the reinforcing properties of abused drugs. 1987;211-227 New York, Springer-Verlag.
59. Tricklebank M.D., Hutson P.H., Curzon G. Analgesia induced by brief footshock is inhibited by 5-hydroxytryptamine but unaffected by antagonists of 5-hydroxytryptamine or by naloxone. Neuropharmacology. 21:1982;51-56.
60. Ulm R.R., Volpicelli J.R., Volpicelli L.A. Opiates and alcohol self-administration in animals. J Clin Psychiatry. 56(suppl 7):1995;5-14.
61. Volpicelli J.R., Anterman A.I., Hayashida M., O'Brien C.P. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry. 49:1992;876-880.
62. Volpicelli J.R., Rhines K.C., Rhines J.S., Volpicelli L.A., Alterman A.I., O'Brien C.P. Naltrexone and alcohol dependence. role of subject compliance Arch Gen Psychiatry. 54:1997;737-742.
63. Weiss F., Mitchiner M., Bloom F.E., Koob G.F. Free-choice responding for ethanol versus water in alcohol prefering (P) and unselected Wistar rats is differentially modified by naloxone, bromocriptine and methysergide. Psychopharmacology. 101:1990;178-186.
64. Zernig G., Fabisch K., Fabisch H. Pharmacotherapy for alcohol dependence. Trends Pharmacol Sci. 18:1997;229-231.